Wright Medical CEO Palmisano Will Oversee Ongoing Cost Cuts
This article was originally published in The Gray Sheet
Executive Summary
Newly appointed Wright Medical CEO Robert J. Palmisano’s near-term focus will include implementing an ongoing restructuring and cost-cutting plan, the first phase of which will be completed over the next nine months, according to the company.
You may also be interested in...
News In Brief
GE boosts cancer commitment
People In Brief
Wright Medical CEO resigns
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.